Lotte Knudsen
Lotte Knudsen is an influential figure at Novo Nordisk, a Danish pharmaceutical company, where she has been pivotal in the development of GLP-1-related drugs such as Ozempic and Wegovy. She shares the Breakthrough Prize in Life Sciences for her contributions to the advancement of treatments for obesity and diabetes.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 9.00 | 0.04% | +0% | 38,005,238 | 16,891 | $1,700,000 | 756$ |
| Totals | 1 | 38,005,238 | 16,891 | $1,700,000 | 756$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Lotte Knudsen was key to the development of the GLP-1 related drugs Ozempic and Wegovy.
9